Calcitonin-gene related peptide and cerebral vasospasm

Journal of Clinical Neuroscience

Volumn 20, Issue 4, 2013, Pages 584-586

  Schebesch, Karl Michael ^a   Herbst, Andreas ^a   Bele, Sylvia ^a   Schödel, Petra ^a   Brawanski, Alexander ^a   Stoerr, Eva Maria ^a   Lohmeier, Annette ^a   Kagerbauer, Simone Maria ^b   Martin, Jan ^b   Proescholdt, Martin ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Calcitonin gene related peptide; Cerebral vasospasm; Neuropeptide Y; Neuropeptides; Subarachnoid hemorrhage

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CLINICAL ARTICLE; COHORT ANALYSIS; DOPPLER ECHOGRAPHY; ENZYME IMMUNOASSAY; EXPERIMENTAL STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGRAPHY, DIGITAL SUBTRACTION; CALCITONIN GENE-RELATED PEPTIDE; CEREBROVASCULAR CIRCULATION; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 84875530829     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.07.006     Document Type: Article

References (26)

1. M.N. Diringer Management of aneurysmal subarachnoid hemorrhage Crit Care Med 37 2009 432 440
2. J.I. Suarez, R.W. Tarr, and W.R. Selman Aneurysmal subarachnoid hemorrhage N Engl J Med 354 2006 387 396
3. J. van Gijn, R.S. Kerr, and G.J. Rinkel Subarachnoid haemorrhage Lancet 369 2007 306 318
4. J.P. Dreier, S. Major, and A. Manning Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage Brain 132 2009 1866 1881
5. M. Lauritzen, J.P. Dreier, and M. Fabricius Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury J Cereb Blood Flow Metab 31 2011 17 35
6. L. von Baumgarten, R. Trabold, and S. Thal Role of cortical spreading depressions for secondary brain damage after traumatic brain injury in mice J Cereb Blood Flow Metab 28 2008 1353 1360
7. J. Cahill, J.W. Calvert, and J.H. Zhang Mechanisms of early brain injury after subarachnoid hemorrhage J Cereb Blood Flow Metab 26 2006 1341 1353
8. M.D. Vergouwen, M. Vermeulen, and B.A. Coert Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia J Cereb Blood Flow Metab 28 2008 1761 1770
9. J. Hansen-Schwartz, P. Vajkoczy, and R.L. Macdonald Cerebral vasospasm: looking beyond vasoconstriction Trends Pharmacol Sci 28 2007 252 256
10. J.D. Pearl, and R.L. Macdonald Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study Acta Neurochir Suppl 105 2008 207 210
11. M.D. Vergouwen, M. Vermeulen, and Y.B. Roos Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon? Stroke 40 2009 e39 [author reply e40]
12. R.L. Macdonald, R.T. Higashida, and E. Keller Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) Lancet Neurol 10 2011 618 625
13. G.J. Velat, M.M. Kimball, and J.D. Mocco Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature World Neurosurg 76 2011 446 454
14. K.M. Schebesch, A. Brawanski, and S.M. Kagerbauer The possible role of neuropeptide Y after spontaneous subarachnoid hemorrhage Acta Neurochir (Wien) 153 2011 1663 1668 [discussion 68]
15. T. Hokfelt, U. Arvidsson, and S. Ceccatelli Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems Ann N Y Acad Sci 657 1992 119 134
16. J. McCulloch, R. Uddman, and T.A. Kingman Calcitonin gene-related peptide: functional role in cerebrovascular regulation Proc Natl Acad Sci USA 83 1986 5731 5735
17. A. Saria, G. Bernatzky, and C. Humpel Calcitonin gene-related peptide in the brain. Neurochemical and behavioral investigations Ann N Y Acad Sci 657 1992 164 169
18. L. Edvinsson, I. Jansen, and M. Cunha e Sa Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries Cephalalgia 14 1994 88 96
19. R. Juul, H. Hara, and S.E. Gisvold Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man Acta Neurochir (Wien) 132 1995 32 41
20. S.M. Kagerbauer, D.M. Kemptner, and C.P. Schepp Elevated premorbid body mass index is not associated with poor neurological outcome in the subacute state after aneurysmal subarachnoid hemorrhage Cent Eur Neurosurg 71 2010 163 166
21. M.G. Rosenfeld, J.J. Mermod, and S.G. Amara Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing Nature 304 1983 129 135
22. J. Hoffmann, and P.J. Goadsby New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors Curr Treat Options Neurol 14 2012 50 59
23. K.L. Chaichana, G. Pradilla, and J. Huang Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage World Neurosurg 73 2010 22 41
24. S. Buervenich, F. Xiang, and O. Sydow Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression Hum Mutat 17 2001 435 436
25. S. Menon, J. Buteri, and B. Roy Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine Brain Res 1378 2011 119 124
26. J.G. De Mey, R. Megens, and G.E. Fazzi Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries J Pharmacol Exp Ther 324 2008 930 937